MARIANNA HELIN: Open Payments
NPI 1881734366 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 64 payments from 11 companies in 2025. Trend: 2023 $1,054 · 2024 $1,156 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $299 |
| Janssen Biotech, Inc. | 11 | $208 |
| E.R. Squibb & Sons, L.L.C. | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Incyte Corporation | 5 | $107 |
| GENZYME CORPORATION | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| UCB, Inc. | 2 | $33 |
| Amgen Inc. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, Sotyktu, OPZELURA, COSENTYX, Bimzelx.
Industry payments across FL — which companies pay providers there.
